• Latest Posts

64 Million RSV Infections Per Year: Perhaps Alpaca Nanobodies Will Save Infant Lives

Ablynx Top Trumps: Adding Danish Diabetes Giant Novo Nordisk to its Biotech Deck

Ablynx richly rewarded for MSD’s Nanobody Proof in Immuno-Oncology

Asceneuron’s latest stab at the Alzheimer’s challenge with Sofinnova

Could an Alpaca’s monoclonal antibodies be used to treat an ultra-rare blood disease?

DNA to play an essential role in the future of Computers?


Ablynx and MSD upgrade their €1.7Bn deal to gigantic €5.7Bn

Genzyme joins the never-ending list of Ablynx’ partners

Ablynx gets tangled up in partnerships with Big Pharma companies

Exclusive interview with Laurent Levy, CEO of Nanobiotix, Leading European Nanomedicine Biotech

Ablynx gain €2.1m to develop a novel Nanobodies for Ocular applications